Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
Search Article 
Advanced search 
  Users Online: 94 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others


Dipeptidyl peptidase-4 inhibitors or sodium glucose co-transporter-2 inhibitors as an add-on to insulin therapy: A comparative review

Singh Awadhesh Kumar, Singh Ritu

Year : 2016| Volume: 20| Issue : 1 | Page no: 32-42

   This article has been cited by
1 Effect of background insulin therapy on cardiovascular outcomes with SGLT-2 inhibitors in type 2 diabetes: A meta-analysis of cardiovascular outcome trials
Awadhesh Kumar Singh,Ritu Singh
Diabetes Research and Clinical Practice. 2021; 172: 108648
[Pubmed]  [Google Scholar] [DOI]
2 Prospect of Sodium–Glucose Co-transporter 2 Inhibitors Combined With Insulin for the Treatment of Type 2 Diabetes
Yinqiu Yang,Chenhe Zhao,Yangli Ye,Mingxiang Yu,Xinhua Qu
Frontiers in Endocrinology. 2020; 11
[Pubmed]  [Google Scholar] [DOI]
3 Histology of Cryopreserved Neonatal Rat Testes After Intratesticular Allotransplantation
Bo Deng,Vitaliy Kireev,Kristina Melentyeva,Igor Kovalenko,Oleksandr Pakhomov
Problems of Cryobiology and Cryomedicine. 2020; 30(1): 034
[Pubmed]  [Google Scholar] [DOI]
4 Identification of barriers to insulin therapy and approaches to overcoming them
David Russell-Jones,Frans Pouwer,Kamlesh Khunti
Diabetes, Obesity and Metabolism. 2017;
[Pubmed]  [Google Scholar] [DOI]


Read this article